Indication
Adjunct therapy for peptic ulcer disease
Adjunct therapy for peptic ulcer disease refers to supportive or secondary pharmacologic intervention used alongside standard acid-suppressive or eradication regimens to manage ulcerative lesions of the upper gastrointestinal tract. Read more about Adjunct therapy for peptic ulcer disease
57 drugs 52 manufacturers
Drugs that treat it
Common Adjunct therapy for peptic ulcer disease therapies.
GLYCOPYRROLATE
GLYCOPYRROLATE
LIBRAX (WITH CLIDINIUM) (chlordiazepoxide/clidinium bromide)
DARTISLA (glycopyrrolate)
CHLORDIAZEPOXIDE-CLIDINIUM (chlordiazepoxide/clidinium bromide)
GLYCOPYRROLATE
CHLORDIAZEPOXIDE-CLIDINIUM (chlordiazepoxide/clidinium bromide)
GLYCOPYRROLATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAdjunct therapy for peptic ulcer disease refers to supportive or secondary pharmacologic intervention used alongside standard acid-suppressive or eradication regimens to manage ulcerative lesions of the upper gastrointestinal tract.
This condition affects the stomach and proximal duodenum, typically presenting clinically with burning epigastric pain, dyspepsia, fullness, and potential complications such as hemorrhage, perforation, or obstruction.
Pathophysiologically, it is characterized by mucosal barrier disruption that penetrates the muscularis mucosae, driven by an imbalance between aggressive luminal factors—principally gastric acid and pepsin—and protective defense mechanisms, most frequently precipitated by *Helicobacter pylori* infection or the use of nonsteroidal anti-inflammatory drugs.
In this clinical setting, adjunctive agents serve as complementary measures to alleviate persistent symptoms, enhance mucosal defense, or reduce gastric secretions when primary curative strategies require augmentation.
- nih.gov
Adjunct therapy for peptic ulcer disease refers to supportive or secondary pharmacologic intervention used alongside standard acid-suppressive or eradication regimens to manage ulcerative lesions of the upper gastrointestinal tract This condition affects the stomach and proximal duodenum, typically presenting clinically with burning epigastric pain, dyspepsia, fullness, and potential complications such as hemorrhage, perforation, or obstruction Pathophysiologically, it is characterized by mucosa...
- nih.gov
Adjunct therapy for peptic ulcer disease refers to supportive or secondary pharmacologic intervention used alongside standard acid-suppressive or eradication regimens to manage ulcerative lesions of the upper gastrointestinal tract
- aafp.org
This condition affects the stomach and proximal duodenum, typically presenting clinically with burning epigastric pain, dyspepsia, fullness, and potential complications such as hemorrhage, perforation, or obstruction Pathophysiologically, it is characterized by mucosal barrier disruption that penetrates the muscularis mucosae, driven by an imbalance between aggressive luminal factors—principally gastric acid and pepsin—and protective defense mechanisms, most frequently precipitated by *Helicobac...
- nih.gov
Pathophysiologically, it is characterized by mucosal barrier disruption that penetrates the muscularis mucosae, driven by an imbalance between aggressive luminal factors—principally gastric acid and pepsin—and protective defense mechanisms, most frequently precipitated by *Helicobacter pylori* infection or the use of nonsteroidal anti-inflammatory drugs
- nih.gov
In this clinical setting, adjunctive agents serve as complementary measures to alleviate persistent symptoms, enhance mucosal defense, or reduce gastric secretions when primary curative strategies require augmentation
- pharmacytimes.com
In this clinical setting, adjunctive agents serve as complementary measures to alleviate persistent symptoms, enhance mucosal defense, or reduce gastric secretions when primary curative strategies require augmentation
Personalize your experience
Follow Adjunct therapy for peptic ulcer disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.